Record #56863
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation
Publisher
Original paper date
Dec 6, 2003
Original DOI
Country
Institution
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Torre Biologica, Policlinico Universitario Via C. Valeria, Gazzi, 98100 Messina, Italy · Department of Experimental Pharmacology, University of Naples Federico II, Italy · Department of Experimental Medicine and Nephrology, The William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
Open access
No
Article type
Notes from Retraction Watch
see also: https://pubpeer.com/publications/3DD8D98CCE390DD5502903BD1954DF
Citation lifecycle
How this paper is being cited
Pre-retraction
197
Same day
0
Post-retraction
3
% post-retraction
1.5%
~9.5 citations/yr before retraction · ~1.5 citations/yr after
— citing papers
Who is still citing this work
Loading…